Longitudinal study of anti-myeloma treatment patterns in a U.S. commercial population before and after approval of bortezomib (BOR). The utility and prognostic value of positron emission tomography ...
A study of patients with pemphigus who were in remission after a rituximab cycle found that administering an additional infusion at month 6, when guided by relapse predictors, significantly improved ...
Rituxan (rituximab) is a brand-name intravenous (IV) infusion prescribed for RA. This article covers topics such as side effects, dosage, and how Rituxan works for RA. Rituxan is a biologic and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results